Vivos (RDGL) Selling, General & Administrative (2010 - 2025)
Vivos (RDGL) Selling, General & Administrative (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | -207.22 Mn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 90,535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90,535.00 |
| Sep 30, 2025 | 72,904.00 |
| Jun 30, 2025 | 80,913.00 |
| Mar 31, 2025 | 52,203.00 |
| Dec 31, 2024 | 98,356.00 |
| Sep 30, 2024 | 65,123.00 |
| Jun 30, 2024 | 54,925.00 |
| Mar 31, 2024 | 23,420.00 |
| Dec 31, 2023 | 32,942.00 |
| Sep 30, 2023 | 31,357.00 |
| Jun 30, 2023 | 57,792.00 |
| Mar 31, 2023 | 43,683.00 |
| Dec 31, 2022 | 39,759.00 |
| Sep 30, 2022 | 38,302.00 |
| Jun 30, 2022 | 34,949.00 |
| Mar 31, 2022 | 37,100.00 |
| Dec 31, 2021 | 29,402.00 |
| Sep 30, 2021 | 22,131.00 |
| Jun 30, 2021 | 30,330.00 |
| Mar 31, 2021 | 35,835.00 |